Please login to the form below

Not currently logged in
Email:
Password:

genetics

This page shows the latest genetics news and features for those working in and with pharma, biotech and healthcare.

GSK joins forces with Doudna’s CRISPR lab

GSK joins forces with Doudna’s CRISPR lab

The partners say the ultimate goal is to deepen understanding of genetics and discover new targets, and to create next generation tech that will become future standard practice for the pharmaceutical ... The collaboration consolidates GSK’s focus on

Latest news

More from news
Approximately 24 fully matching, plus 601 partially matching documents found.

Latest Intelligence

  • Rare disease trials Q&A Rare disease trials Q&A

    Characterised by small, highly heterogeneous patient populations, including children in almost half of the cases, rare diseases are usually genetic and therefore chronic.

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Given that 80% of 7, 000 or so rare diseases have a genetic component, gene therapies have the potential to provide meaningful improvements in the lives of patients with rare diseases.

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    Second is the dominant therapeutic areas. The list almost fully comprises agents targeting genetic disorders or aberrant immune responses. ... Covering a wide range of conditions, and with the recurring themes of genetic modification and immune modulation

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    Alzheimer’s hits early in genetic subpopulations with high levels of Abeta but, despite these apparent links between the peptides and disease, clinical programmes targeting plaques have failed.

  • Bringing life to precision medicine Bringing life to precision medicine

    The outcomes of this study show that this functional approach to precision medicine may have enormous potential for improving the results achieved with genetic sequencing alone.

More from intelligence
Approximately 1 fully matching, plus 82 partially matching documents found.

Latest appointments

  • Health comms agency emotive hires new cell and gene therapy leader Health comms agency emotive hires new cell and gene therapy leader

    Silvana holds a PhD in Molecular Genetics from the Human Molecular Genetics Unit at the University of Insurbia in Italy.

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Prior to this, he served as executive vice president of commercial for Seattle Genetics, where he led all commercial activities for the company. ... The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Their combined experience in corporate strategy, business development and commercialisation will be invaluable to the company’s continued growth as we advance our clinical programmes in blood cancers and rare genetic

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Carsten Thiel joins the biopharma from Alexion. Rare genetic disease focused biopharma Abeona Therapeutics has named its chief executive officer in the form of Carsten Thiel.

  • Sophia Genetics appoints CFO Sophia Genetics appoints CFO

    Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance. ... approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”.

More from appointments
Approximately 3 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 17 fully matching, plus 59 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics